about
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron functionMultifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentNew perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failureChronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.ACE2 improves right ventricular function in a pressure overload model.ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic functionRole of olmesartan in combination therapy in blood pressure control and vascular function.Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injuryOxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats.Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.Angiotensin-converting enzyme 2: the first decade.Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy.Angiotensin-(1-7)-mediated signaling in cardiomyocytes.Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis ratsDecreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureInhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomilCardiovascular effects of losartan and its relevant clinical application.Angiotensin-converting enzyme 2 as a therapeutic target for heart failureNew physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.ACE2: more of Ang-(1-7) or less Ang II?Role of ACE2 in diastolic and systolic heart failure.New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.Angiotensin converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment.Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).Ontogeny of angiotensin-converting enzyme 2.Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1α nuclear translocation via Mas receptor regulation.Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
P2860
Q24633556-FAAD6F10-19D1-4C50-BC8E-CB1A7A128123Q28086792-ACFBA541-7F86-46B0-B82B-5779B6CB82D1Q28541744-2DE63877-2538-44CB-A6CE-1942477FA4F4Q33881270-125B75FC-5417-42E0-97DE-E48B4EEC48C0Q33939495-4E6AAC95-9E70-4784-93B4-95F600DBA37BQ33983361-17A1A78D-14A4-4A6F-9E8C-431DA1061B77Q34139061-2B7F6EBF-5F94-40BA-8B21-888A65AD9CC5Q34799585-57788A77-0FE3-4CE4-B0A1-419679AA19E5Q34866649-D3AB2296-4627-4798-ADA5-FF37D165FDD3Q35135715-1CB70C87-C560-4CDC-BF5B-E634A86E6C72Q35152116-50507D5D-30D6-4016-A16D-93DEB984A665Q35550937-98A116AA-BD64-462C-A322-83A0EB8E4AFEQ35749652-B73FF8E8-8CC1-4465-AF2A-44ED96E410A9Q35790978-0204C8D3-807C-4837-B50D-1CCB6156AB90Q35829928-D3F36497-A75D-4A6B-AA0B-3337D30F2635Q35889735-57F3BAAA-5EE1-43BE-B153-CF972720023DQ36087047-84AE2A5D-21C4-477E-B52B-CA21FF1069CEQ36208883-230EB6D4-0EC6-4150-8818-F82B88B5931AQ36241932-69060D48-CF07-4602-A77A-0579E756E3B3Q36714100-07AEF2C1-23CE-45B1-9CDA-333A57E48592Q36853840-BA5B0BDA-E4EF-466B-B220-08536302624EQ37070124-F6DA56F4-3136-4C9C-8EF1-E13B0A582A2BQ37081415-D7A49097-6D74-492B-B3A9-6BB4E5671B71Q37084921-9FD760B9-57F4-499A-9A5E-B3DD93F2F03BQ37167510-5F0124DD-7A15-45C6-A744-6E826F0CF9A2Q37595599-92D6636B-EDA2-4555-AD38-053B7F242E8AQ37620934-DDDC73BC-BFFB-4780-BBBA-ABE85DDDFD14Q37660786-CA523416-9EA1-47EA-A6F2-3FB4279E8096Q37679270-4E6417A7-6188-4148-AFC3-22D48745C667Q37806553-E1040654-D109-4B43-9BA4-9BFCD46ACD0BQ37884450-3796E959-F87F-4E39-8763-69148006C5C0Q37982718-48BAA8B5-256B-4C17-B199-029FF03C50A6Q38567063-7C013441-9C54-42AB-8833-2D9673B12EB5Q38612115-C4517789-D629-446F-B695-D4BD53084FBBQ39420474-C32448F4-0C71-44BD-B096-45441B2E7FB9Q39694429-2247A523-5FCF-45CE-A632-B3DCF96B3234Q47851502-25FF807A-D500-4879-9481-1BD63363AD89Q48684263-DC4059F6-63E1-4207-91B6-B8FD4EE9F9AAQ51534336-F6127E98-C97B-4A81-B16D-49A969FE83A5Q51590953-92BBF75F-E5D5-448C-9A92-F4DF64822E46
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@en
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@nl
type
label
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@en
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@nl
prefLabel
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@en
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@nl
P2093
P2860
P1476
Regulation of ACE2 in cardiac myocytes and fibroblasts.
@en
P2093
Carlos M Ferrario
E Ann Tallant
Patricia E Gallagher
P2860
P304
P356
10.1152/AJPHEART.00426.2008
P577
2008-10-10T00:00:00Z